| Literature DB >> 21423408 |
Harmen J Krugers1, Casper C Hoogenraad.
Abstract
Humans and rodents retain memories for stressful events very well. The facilitated retention of these memories is normally very useful. However, in susceptible individuals a variety of pathological conditions may develop in which memories related to stressful events remain inappropriately present, such as in post-traumatic stress disorder. The memory enhancing effects of stress are mediated by hormones, such as norepinephrine and glucocorticoids which are released during stressful experiences. Here we review recently identified molecular mechanisms that underlie the effects of stress hormones on synaptic efficacy and learning and memory. We discuss AMPA receptors as major target for stress hormones and describe a model in which norepinephrine and glucocorticoids are able to strengthen and prolong different phases of stressful memories.Entities:
Keywords: AMPA receptor trafficking; glucocorticoids; memory; norepinephrine; stress
Year: 2009 PMID: 21423408 PMCID: PMC3059607 DOI: 10.3389/neuro.19.002.2009
Source DB: PubMed Journal: Front Synaptic Neurosci ISSN: 1663-3563
Figure 1Stress hormones enhance memory formation. Exposure to a fearful event rapidly activates the autonomic nervous system and enhances norepinephrine levels in the brain. At the same time the hypothalamo–pituitary-adrenal (HPA) axis is activated which causes a slow increase in plasma corticosterone levels. These hormones act via their receptors, which are present in regions that are critical for memory formation such as hippocampus, amygdala, and prefrontal cortex, to promote memory consolidation. For details see text. LC: Locus Coeruleus, Prefr. Cortex: Prefrontal Cortex.
Figure 2Differential effects of stress hormones on AMPA receptor trafficking. During the initial phase after stress exposure when norepinephrine (NE) are rapidly and reversible released activation of β-ARs and corticosteroid hormones via MRs modulate synaptic function; release probability, lateral diffusion, synaptic incorporation of GluR1/2 containing AMPA receptors, and (threshold for) LTP is enhanced. These effects require non-genomic actions. Second, corticosteroid levels slowly rise, return to baseline, but these hormones can have persistent genomic actions via GR activation. Via GR activation these hormones increase synaptic incorporation of GluR2/3 containing AMPA receptors, increase lateral diffusion, and suppress LTP.